Evaluating next‑generation cloud compute for large‑scale genomic processing
AstraZeneca’s genomic research requires extensive computational resources to analyze DNA sequences for developing life-saving therapies. As cloud infrastructure evolves with more powerful capabilities, customers can adopt them to see performance and efficiency gains. AstraZeneca successfully migrated to Amazon EC2 F2 instances for genomics, boosting performance by 60% and slashing costs by 70%.